TRML
Tourmaline Bio
TRML
TRML
Delisted
TRML was delisted on the 27th of October, 2025.
0 hedge funds and large institutions have $0 invested in Tourmaline Bio in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 132 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 132
Holders
–
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$122M | |
| 2 | -$103M | |
| 3 | -$72.6M | |
| 4 |
TCM
TCG Crossover Management
Palo Alto,
California
|
-$62.7M |
| 5 |
P
Pfizer
New York
|
-$60.8M |
